Insider holders · CIK 0001070336
ACHILLION PHARMACEUTICALS INC · ACHN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Peter Kolchinsky10% Owner | 4,816,562 | — | 4,816,562 | Jan 20, 2015 · 6:10 pm EST | Form 4 |
| RA CAPITAL MANAGEMENT, LLCrelationship not stated | 4,816,562 | — | 4,816,562 | Jan 20, 2015 · 6:10 pm EST | Form 4 |
| RA Capital Healthcare Fund LP10% Owner | 4,816,562 | — | 4,816,562 | Jan 20, 2015 · 6:10 pm EST | Form 4 |
| David ScheerDirector | 20,000 | 63,249 | 83,249 | Dec 18, 2018 · 4:24 pm EST | Form 4 |
| Jason S FishermanDirector | 70,000 | 1,500 | 71,500 | Jun 8, 2018 · 4:15 pm EDT | Form 4 |
| Nicole VitulloDirector | 36,431 | 25,159 | 61,590 | Jun 4, 2018 · 4:20 pm EDT | Form 4 |
| Robert L Van NostrandDirector | 20,000 | — | 20,000 | Dec 18, 2018 · 4:22 pm EST | Form 4 |
| Keri LantzSee Remarks | 11,848 | — | 11,848 | Jan 7, 2019 · 5:35 pm EST | Form 3 |
| Joseph TruittChief Commercial Officer | 3,500 | — | 3,500 | Dec 5, 2016 · 5:18 pm EST | Form 4 |
| Joel C BarrishChief Scientific Officer | 2,500 | — | 2,500 | Dec 5, 2016 · 5:15 pm EST | Form 4 |
| Mary Kay FentonChief Financial Officer | 2,500 | — | 2,500 | Dec 5, 2016 · 5:16 pm EST | Form 4 |
| Milind DeshpandeChief Executive Officer | 2,500 | — | 2,500 | Dec 5, 2016 · 5:16 pm EST | Form 4 |
| Martha E ManningEVP, General Counsel | 2,500 | — | 2,500 | Dec 5, 2016 · 5:17 pm EST | Form 4 |
| Brian Di DonatoChief Financial Officer | 0 | — | 0 | Feb 11, 2019 · 6:23 pm EST | Form 3 |
| Anthony S GibneyChief Business Officer | 0 | — | 0 | Aug 16, 2018 · 5:33 pm EDT | Form 3 |
| Paul E FirutaChief Operating Officer | 0 | — | 0 | Sep 12, 2018 · 5:56 pm EDT | Form 3 |
| Steven ZelenkofskeChief Medical Officer | 0 | — | 0 | Aug 21, 2018 · 6:23 pm EDT | Form 3 |
| David ApelianChief Medical Officer | 0 | — | 0 | Dec 30, 2015 · 4:26 pm EST | Form 4 |
| Frank VerwielDirector | 0 | — | 0 | Dec 16, 2015 · 4:44 pm EST | Form 3 |
| Johnson & Johnson Innovation - JJDC, Inc.10% Owner | — | 0 | 0 | Nov 22, 2017 · 11:44 am EST | Form 4 |
| JOHNSON & JOHNSON10% Owner | — | 0 | 0 | Nov 22, 2017 · 11:44 am EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.